Dr. Boruchov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
21 Elm St
New Milford, CT 06776- Is this information wrong?
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1997 - 2000
- State University of New York Downstate Medical Center College of MedicineClass of 1997
Certifications & Licensure
- CT State Medical License 2008 - 2024
- NY State Medical License 1998 - 2010
- American Board of Internal Medicine Hematology
Clinical Trials
- Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma Start of enrollment: 2012 Dec 01
- A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) Start of enrollment: 2014 Jul 14
Publications & Presentations
PubMed
- 8 citationsImmune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma.Romanos Sklavenitis-Pistofidis, Michelle P Aranha, Robert A Redd, Joanna Baginska, Nicholas J Haradhvala, Margaret Hallisey, Ankit K Dutta, Alexandra Savell, Shohreh V...> ;Cancer Cell. 2022 Nov 14
- 15 citationsRomidepsin and lenalidomide-based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohortsNeha Mehta-Shah, Matthew A. Lunning, Alison J. Moskowitz, Adam M. Boruchov, Jia Ruan, Peggy Lynch, Paul A. Hamlin, John P. Leonard, Matthew J. Matasar, Patricia L. Mys...> ;American Journal of Hematology. 2021 Jul 12
- 39 citationsPhase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.Irene M. Ghobrial, Chia Jen Liu, Oksana Zavidij, Abdel Kareem Azab, Rachid Baz, Jacob P. Laubach, Yuji Mishima, Philippe Armand, Nikhil C. Munshi, Frank G. Basile, Mic...> ;American Journal of Hematology. 2019 Nov 1
- Join now to see all
Press Mentions
- Yale Researchers Say Customized Cancer Vaccine Shows PromiseMay 20th, 2023
- Study Shows That Immune System Holds Clues to Patients with High-Risk Smoldering Myeloma Likely to Benefit from TreatmentNovember 15th, 2022
- Nuvance Health Appoints Adam Boruchov, MD, System Chair of the Cancer InstituteOctober 26th, 2023
Grant Support
- Targeting Fcrs On Dcs For Ag-Specific ToleranceNational Institute Of Allergy And Infectious Diseases2005–2008
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: